John Oyler sold $35M of ONC
Chief Executive Officer at BeiGene, Ltd.. 109,713 shares at an average of $315.28, traded Jul 20, 2026, filed Jul 22, 2026.
Score components
- +25RoleCEO
- +25Trade size$34.6M at market
- +20Share of holdings soldSold 100% of holdings
- +15Cluster3 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001042047-26-000017, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jul 20, 2026 | SOpen-market sale American Depositary Shares10b5-1 | -5,146 | $310.08 | $1.6M | 9,180 | Jul 22, 2026 |
| Jul 20, 2026 | SOpen-market sale American Depositary Shares10b5-1 | -6,273 | $310.75 | $1.9M | 2,907 | Jul 22, 2026 |
| Jul 20, 2026 | SOpen-market sale American Depositary Shares10b5-1 | -2,907 | $311.80 | $906k | 0 | Jul 22, 2026 |
| Jul 20, 2026 | MOption exercise American Depositary Shares10b5-1 | +33,990 | $119.96 | $4.1M | 33,990 | Jul 22, 2026 |
| Jul 20, 2026 | SOpen-market sale American Depositary Shares10b5-1 | -15,499 | $312.29 | $4.8M | 18,491 | Jul 22, 2026 |
| Jul 20, 2026 | SOpen-market sale American Depositary Shares10b5-1 | -14,326 | $312.96 | $4.5M | 4,165 | Jul 22, 2026 |
| Jul 20, 2026 | SOpen-market sale American Depositary Shares10b5-1 | -1,850 | $313.91 | $581k | 2,315 | Jul 22, 2026 |
| Jul 20, 2026 | SOpen-market sale American Depositary Shares10b5-1 | -1,512 | $315.26 | $477k | 803 | Jul 22, 2026 |
| Jul 20, 2026 | SOpen-market sale American Depositary Shares10b5-1 | -523 | $316.14 | $165k | 280 | Jul 22, 2026 |
| Jul 20, 2026 | SOpen-market sale American Depositary Shares10b5-1 | -280 | $318.30 | $89k | 0 | Jul 22, 2026 |
| Jul 21, 2026 | SOpen-market sale American Depositary Shares10b5-1 | -15,379 | $316.26 | $4.9M | 46,018 | Jul 22, 2026 |
| Jul 21, 2026 | SOpen-market sale American Depositary Shares10b5-1 | -20,029 | $316.91 | $6.3M | 25,989 | Jul 22, 2026 |
| Jul 21, 2026 | SOpen-market sale American Depositary Shares10b5-1 | -7,842 | $318.41 | $2.5M | 18,147 | Jul 22, 2026 |
| Jul 21, 2026 | SOpen-market sale American Depositary Shares10b5-1 | -15,807 | $319.29 | $5.0M | 2,340 | Jul 22, 2026 |
| Jul 21, 2026 | SOpen-market sale American Depositary Shares10b5-1 | -2,340 | $320.06 | $749k | 0 | Jul 22, 2026 |
| Jul 20, 2026 | MOption exercise Share Option (Right to Buy)derivative10b5-1 | -441,870 | $0.00 | $0 | 0 | Jul 22, 2026 |
Related signals
Other insiders at BeiGene, Ltd. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 39Weak | BeiGene, Ltd. | Chan Henry Lee SVP, General Counsel | $418k 1,115 shares | -100% | |
| 33Weak | BeiGene, Ltd. | Xiaodong Wang director, other | $11M 31,028 shares | -100% | |
| 40Moderate | BeiGene, Ltd. | Xiaodong Wang director, other | $13M 38,287 shares | -527% | |
| 56Moderate | BeiGene, Ltd. | Titus B. Ball Principal Accounting Officer | $47k 132 shares | -100% | |
| 45Moderate | BeiGene, Ltd. | Xiaobin Wu President and COO | $106k 280 shares | -100% | |
| 39Weak | BeiGene, Ltd. | Chan Henry Lee SVP, General Counsel | $960k 2,666 shares | -100% | |
| 65Notable | BeiGene, Ltd. | John Oyler Chief Executive Officer | $86M 240,810 shares | -100% | |
| 72Notable | BeiGene, Ltd. | Aaron Rosenberg Chief Financial Officer | $362k 1,157 shares | -100% | |
| 65Notable | BeiGene, Ltd. | Chan Henry Lee SVP, General Counsel | $338k 1,044 shares | -100% | |
| 34Weak | BeiGene, Ltd. | Chan Henry Lee SVP, General Counsel | $542k 1,669 shares | -100% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.